PEAK6 Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

PEAK6 Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-210,600	Closed	-$36.4M	–	5956
2015 Q1	$36.4M	Buy	210,600 +194,700	+1,225%	+$28.6M	0.28%	36
2014 Q4	$1.83M	Buy	15,900 +7,000	+79%	+$848K	0.01%	1415
2014 Q3	$1.39M	Buy	8,900 +4,200	+89%	+$609K	0.01%	1547
2014 Q2	$580K	Sell	4,700 -12,500	-73%	-$1.38M	0.01%	2177
2014 Q1	$1.78M	Buy	+17,200	New	+$1.76M	0.02%	1362

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

PEAK6 Group's SLXP Position: Q1 2015 in Review

PEAK6 Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 7,435 shares — an estimated $1.09M sold.

PEAK6 Group first reported a position in SLXP in Q4 2013 and held it in 5 quarters. The position peaked at $1.63M in Q1 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

PEAK6 Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
PEAK6 Group sold 7,435 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $1.09M.
PEAK6 Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2013 and held it in 5 quarters.
PEAK6 Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.63M in Q1 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on PEAK6 Group's 13F filing for Q1 2015, filed 13 May 2015.